M&G plc’s Halozyme HALO Stock Holding History

M&G plc’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-160,435	Closed	-$11.7M	–	398
2025 Q3	$11.7M	Buy	+160,435	New	+$10.7M	0.06%	187
2024 Q4	–	Sell	-153,066	Closed	-$8.72M	–	438
2024 Q3	$8.72M	Buy	+153,066	New	+$8.78M	0.03%	241

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

M&G plc's HALO Position: Q4 2025 in Review

M&G plc sold out of Halozyme (HALO) in Q4 2025, closing a stake of 160,435 shares — an estimated $11.7M sold.

M&G plc first reported a position in HALO in Q3 2024 and held it in 2 quarters. The position peaked at $11.7M in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

M&G plc reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
M&G plc sold 160,435 Halozyme shares in Q4 2025, an estimated $11.7M.
M&G plc first reported a position in Halozyme in Q3 2024 and held it in 2 quarters.
M&G plc's Halozyme position peaked at $11.7M in Q3 2025.
617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on M&G plc's 13F filing for Q4 2025, filed 12 Feb 2026.